Skip to main content
Article thumbnail
Location of Repository

MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA

By A. Phillips and J.P. Blaydes


Regulation of the synthesis, function and degradation of HDM2 (Mdm2 in mouse) plays a key role in controlling the abundance and activity of the transcription factor p53, with consequent implications for the proliferation and survival of normal and cancer cells. We have previously identified the regulation of export of HDM2 mRNA from the nucleus as a novel point of control of HDM2 synthesis. This process is dependent on the activity of the growth factor-regulated MAP-kinase kinases ( MEKs). Here, we provide evidence that the eIF4E kinase MNK1 is a key downstream effector of MEKs in this regulatory pathway. We show that HDM2 mRNA export in breast cancer cells is promoted by overexpressed eIF4E in a MEK- and MNK1-dependent manner, and inhibition of MNK1 suppresses endogenous HDM2 mRNA export pathways. This MNK1- and eIF4E-dependent HDM2 regulation occurs through sequences in the 30 untranslated region of HDM2 mRNA, and consequently HDM2 mRNA transcripts from both the constitutive P1 and inducible P2 promoters are regulated by this pathway. eIF4E is a known oncogene that is overexpressed in human tumours, including the majority of breast cancers. This pathway, therefore, may play an important role in the dysregulation of HDM2 oncoprotein expression that occurs in many human tumours

Topics: QH426
Year: 2008
OAI identifier:
Provided by: e-Prints Soton

Suggested articles


  1. (2006a). GC-selective DNA-binding antibiotic, Mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis.
  2. (1995). A functional p53-responsive intronic promoter is contained within the human mdm2 gene.
  3. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
  4. (2007). A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.
  5. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas.
  6. Blaydes JP (2006b). The mechanisms of regulation of Hdm2 protein level by serum growth factors.
  7. (2007). Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.
  8. (2001). Delineation of mRNA export pathways by the use of cell-permeable peptides.
  9. (2006). eIF4E is a central node of an RNA regulon that governs cellular proliferation.
  10. (2005). eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR.
  11. (2004). eIF4E-from translation to transformation.
  12. Filipovic Z et al (2004). In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
  13. (1993). In vitro growth charcteristics of embryo fibroblasts isolated from p53- deficient mice.
  14. (1993). Mapping of the p53 and mdm-2 interaction domains.
  15. (2004). MDM2 and prognosis.
  16. (2005). MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
  17. Morrice N et al (2005). The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1.
  18. Neering SJ et al (2003). Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
  19. (2001). Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.
  20. (2004). Nuclear export of mRNA: from the site of transcription to the cytoplasm.
  21. (2003). Nuclear RNA export.
  22. (2003). Organizing mRNA export.
  23. (2003). p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results 13 in elevated hdm2 expression in estrogen receptor alpha positive breast cancer cells.
  24. (2004). Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
  25. Rajasekhar VK et al (2007). Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation.
  26. Sasazuki T et al (2000). Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
  27. (2000). Surfing the p53 network.
  28. (2001). The evolution of diverse biological responses to DNA damage: insights from yeast and p53.
  29. (2004). The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.
  30. (1998). The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2.
  31. (1997). Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
  32. (1996). Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
  33. (1997). Yayon A et al

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.